MAPK1 and neoplasm: It accelerates tumor growth by silencing tumor suppressors and DNA repair genes, influences the activity of immune and endothelial cells via CXCL1 and CXCL2 [13] and inactivates ERK, NF-kB and PI3K-AKT pathways resulting in increased levels of β-catenin signaling [5].